SPLSTARPHARMA HOLDINGS LIMITEDMarket sensitive

Upfront payment of USD $5.5 million received from Genentech

Date and time
Announcement type
Company Update
Show details
Category
Other
Report codes
11001
Sector
Health Care
Industry group
Pharmaceuticals, Biotechnology & Life Sciences
View on ASXOpen original PDFSPL announcement history

Recent SPL announcements